Use of nebulised prostacyclin to ascertain reversibility of secondary pulmonary hypertension

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 2, 1996, Pages 234-235

  McGinn, P V ^a   Black, A J R ^b  

^a ST JOHN OF GOD HOSPITAL   (Australia)

^b GEELONG HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; NITROPRUSSIDE SODIUM; PROSTACYCLIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; HEART OUTPUT; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITRAL VALVE REGURGITATION; NEBULIZER; PULMONARY HYPERTENSION;

EID: 0029899843     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00894.x     Document Type: Article

References (6)

1. Murali S, Uretsky BF, Armitage JM et al. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 1992; 11: 716-23.
2. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-4.
3. Williams TJ, Salamonsen RF, Snell G, Kaye D, Esmore DS. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995; 14: 419-23.
4. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1993; 25: 329-40.
5. Bindl L, Fahnenstich H, Peukert U. Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed 1994; 71: F214-6.
6. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W. Effects of aerosolized prostacyclin in severe pneumonia. Am J Resp Crit Care Med 1995; 151: 724-30.